Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11347386 | 0.84 | CYP3A4 (0.49) | CYP3A4USP2MAPK1SMN1; SMN2CYP2D6 | |
| SCHEMBL4377842 | 0.81 | CYP3A4 (0.53) | CYP3A4USP2MAPK1SMN1; SMN2CYP2D6 | |
| SCHEMBL20051613 | 0.81 | LMNA (0.49) | LMNASMN1; SMN2PRKCZKDM4EGAA | |
| SCHEMBL4155014 | 0.80 | TAAR1 (0.62) | LMNASMN1; SMN2MAPTKDM4EGAA | |
| SCHEMBL7945916 | 0.79 | CYP3A4 (0.55) | CYP3A4USP2MAPK1SMN1; SMN2CYP2D6 | |
| SCHEMBL4151139 | 0.79 | CYP3A4 (0.55) | CYP3A4USP2MAPK1SMN1; SMN2CYP2D6 | |
| SCHEMBL10793237 | 0.78 | TP53 (0.71) | LMNASMN1; SMN2MAPTTP53GAA | |
| SCHEMBL7799270 | 0.78 | KDM4E (0.69) | SMN1; SMN2MAPTKDM4EGAA | |
| Diethylamine SCHEMBL10427701 | 0.77 | LMNA (0.49) | CYP3A4LMNAUSP2MAPK1SMN1; SMN2 | |
| Diethylamine SCHEMBL10476846 | 0.77 | LMNA (0.49) | LMNAMAPK1SMN1; SMN2MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101489988-A | Process for alkenylation of carboxamides | BASF AG (DE) | 2009-07-22 | — | — | CN | disclosed |
| US-20090131657-A1 | PROCESS FOR ALKENYLATING CARBOXAMIDES | BASF SE (DE) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131657-A1 | PROCESS FOR ALKENYLATING CARBOXAMIDES | PRMT5, CYC1, CBR3 | CYP3A4 1160/4885LMNA 2037/4885USP2 1766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.